In utero per - and polyfluoroalkyl substances (PFAS) exposure and changes in infant T helper cell development among
Darline Castro Meléndez1, Nathan Laniewski2, Todd A Jusko3
1Department of Immunology, Microbiology and Virology, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States.
Insights
Prenatal exposure to PFAS chemicals alters infant T-cell development, impacting immune responses. Higher PFAS levels were linked to changes in T-follicular helper and T-helper 2 cells by 12 months of age.
Area of Science:
- Immunology
- Environmental Health
- Developmental Biology
Background:
- Prenatal exposure to toxicants like PFAS can disrupt immune development.
- T-cells are crucial for orchestrating immune responses.
- Early life PFAS exposure effects on infant T-cell development are not well understood.
Purpose of the Study:
- To model longitudinal changes in CD4+ T-cell subpopulations from birth to 12 months.
- To investigate the association between in-utero PFAS exposure and infant T-cell development.
Main Methods:
- Maternal-infant dyads were recruited (n=200) and followed for one year.
- Maternal serum PFAS concentrations were measured during pregnancy.
- Infant lymphocyte frequencies were assessed using mass cytometry and analyzed with linear mixed-effects models.
Main Results:
- In-utero PFAS exposure correlated with changes in multiple infant CD4+ T-cell subpopulations.
- Significant associations were observed for T-follicular helper (Tfh) and T-helper 2 (Th2) cells at 12 months.
- Increased PFOS exposure was linked to lower Tfh and higher Th2 cell percentages.
Conclusions:
- Maternal PFAS exposure is associated with cell-specific alterations in the infant T-cell compartment.
- These changes may impact the development of well-regulated, protective immunity in children.
- Further research is needed to explore PFAS-associated T-cell distribution and adverse immune outcomes.
Background:
Environmental exposures to toxicants, such as per- and polyfluoroalkyl substances (PFAS), during gestation can disrupt immune development, causing long-term impacts on a child's ability to generate a well-regulated, protective immune response. T-cells coordinate with all immune cell types to orchestrate both cellular and antibody-mediated responses. While there is compelling evidence that PFAS alters immunity in humans, the specific effects of early life PFAS exposure on infant T-cell development are unreported. Because of their central role in immunity, altered T-cell development in infants would have implications on immune responses broadly and long-term.
Objectives:
We seek to model longitudinal changes in the frequency of functionally distinct CD4+ T-cell subpopulations from birth through 12 months and their association with in-utero PFAS exposure.
Methods:
Maternal-infant dyads were recruited as part of the UPSIDE-ECHO cohort during the first trimester between 2015 and 2019 in Rochester, New York; dyads were followed through the infant's first birthday. Maternal PFAS concentrations (PFOS, PFOA, PFNA, PFHXS and PFDA) were quantified in serum during the second trimester using high-performance liquid chromatography and tandem mass spectrometry. Infant lymphocyte frequencies were assessed at birth, 6- and 12-months using mass cytometry and high-dimensional clustering methods. Linear mixed-effects models were employed to analyze the relationship between maternal PFAS concentrations and CD4+ T-cell subpopulations (n=200). All models included a PFAS and age interaction and were adjusted for parity, infant sex, and pre-pregnancy body mass index.
Results:
In-utero PFAS exposure correlated with multiple CD4+ T-cell subpopulations in infants. The greatest effect sizes were seen in T-follicular helper (Tfh) and T-helper 2 (Th2) cells at 12 months. A log2-unit increase in PFOS was associated with lower Tfh [0.17% (95%CI: -0.30, -0.40)] and greater Th2 [0.27% (95%CI: 0.18, 0.35)] cell percentages at 12 months. Similar trends were observed for PFOA, PFNA, PFHXS and PFDA. TEXT.
Discussion:
Maternal PFAS exposures correlate with cell-specific changes in the infant T-cell compartment, including key CD4+ T-cell subpopulations that play central roles in coordinating well-regulated, protective immunity. Future studies into the role of PFAS-associated T-cell distribution and risk of adverse immune-related health outcomes in children are warranted. https://doi.org/10.1289/EHP16726.
Related Concept Videos
Teratogenicity
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...


